S
Sanity Group
Biotech & Life Sciences · Berlin, Germany · Founded 2018
Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and well-being products MoreLess
A holding company specializing in cannabinoid-based products, with a focus on pharmaceuticals, wellbeing, and cosmetics. The company's business model includes the import, distribution, and development of CBD and THC products across Europe.
Sanity Group operates in the European cannabis market, targeting both the medical and wellness sectors. The company's revenue is generated through the sale of its diverse product portfolio, which includes medical cannabis brands like ZOIKS, as well as other wellbeing and cosmetic items. The company is also actively involved in shaping the legal cannabis market in Germany through participation in scientific pilot projects for the establishment of specialized cannabis stores.
Keywords: cannabinoids, medical cannabis, pharmaceuticals, wellbeing products, CBD, THC, European cannabis market, cannabis distribution, cannabis research, cosmetic products
Talent graph
Sanity Group's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Sanity Group has talent and traffic
team presence
across markets
Market sentiment
What the market is saying about Sanity Group
An AI-synthesized read of the highest-engagement posts about Sanity Group on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sanity Group on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.